News
Dr Soniya Nityanand, a renowned hematologist at SGPGIMS, has led key research in immune disorders, developed a bone marrow transplant programme, and advanced hematology in India.
The study suggests that digital inhalers may reduce the incidence of severe asthma exacerbations, particularly in patients at ...
3.1 Antibody-drug conjugates 3.1.1 Rova-T. Rova-T, the first DLL3-targeting ADC developed for extensive-stage SCLC (ES-SCLC), combines a humanized monoclonal antibody with a DNA cross-linker payload ...
Check the NEET PG Syllabus 2025, including weightage, subject-wise topics, prep tips, and best books in this article.
Background. Sepsis was defined as a life-threatening organ dysfunction caused by a deregulated inflammatory response to infection in the Third International Consensus Definitions released in 2016 ...
Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases. Sanofi will pay $129 per share in cash for the US ...
Mucosal Immunology, Innate Lymphoid Cells, Neuroimmune Regulation, Tissue Homeostasis, Chronic inflammation, Circadian Immunology Research overview The Integrated Mucosal Immunity Lab, led by ...
Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib.
The acquisition includes a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Furthermore, ...
Nature Immunology is a multidisciplinary journal that publishes papers of the highest quality and significance in all areas of immunology. Priority is given to work that provides fundamental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results